Teva Pharmaceutical Industries Limited financial statements, including revenue, expenses, profit, and loss

The total revenue of TEVA for the last quarter is 4.48 B USD, and it's 17.01% higher compared to the previous quarter. The net income of Q4 23 is 462.00 M USD.